Yang, Huiqin; Craig, Dawn; Epstein, David; Bojke, Laura; … - In: PharmacoEconomics 30 (2012) 4, pp. 257-270
-Plough/Centocor) to submit evidence for the clinical and cost effectiveness of this drug for the treatment of active and progressive … comparator biologics. The ERG identified a number of issues relating to the cost-effectiveness results. The manufacturer … calculated incremental cost-effectiveness ratios (ICERs) incorrectly by comparing golimumab with palliative care instead of the …